Sandra G. Demuth

Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant

Susan B. Dillon, Sandra G. Demuth, Mark Schneider et al. · Vaccine · 1992 · 52 citations

Life Sciences, Immunology, Infectious Diseases +17

The Pharmacokinetics, Antigenicity, and Fusion-Inhibition Activity of RSHZ19, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, in Healthy Volunteers

Daniel E. Everitt, Charles B. Davis, Katherine A. Thompson et al. · The Journal of Infectious Diseases · 1996 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +15

Evaluation of the Protective Efficacy of Reshaped Human Monoclonal Antibody RSHZ19 against Respiratory Syncytial Virus in Cotton Rats

Philip R. Wyde, Donna K. Moore, T W Hepburn et al. · Pediatric Research · 1995 · 44 citations

Life Sciences, Immunology, Infectious Diseases +11

Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.

Charles B. Davis, T W Hepburn, J J Urbanski et al. · Drug Metabolism and Disposition · 1995 · 33 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein

Innocent N. Mbawuike, Susan B. Dillon, Sandra G. Demuth et al. · Vaccine · 1994 · 21 citations

Veterinary Medicine, Immunology, Infectious Diseases +10